- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
Results
8674
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,674 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
505283 | ₹1,563.00 | -3.9% | 170.8% | ₹98.2b | ₹1,833.00 | PE53.5x | E26.3% | 0.4% | Capital Goods | ||
DOMS | ₹2,687.30 | -4.8% | n/a | ₹157.7b | ₹3,030.29 | PE87.8x | E22.9% | 0.09% | Commercial Services | ||
ACI | ₹679.80 | -0.9% | 28.1% | ₹83.5b | ₹835.29 | PE38.2x | E41.9% | 0.4% | Materials | ||
CONCORDBIO | ₹1,897.75 | 3.8% | 45.3% | ₹193.9b | ₹1,851.50 | PE60.5x | E26.9% | 0.5% | Pharmaceuticals & Biotech | ||
ANUP | ₹3,534.35 | 0.4% | 156.6% | ₹64.9b | ₹3,850.00 | PE59x | E21.5% | 0.2% | Capital Goods | ||
NOHAL | NOK 25.00 | 2.5% | 22.5% | NOK 977.7m | NOK 32.50 | PS11.6x | E63.9% | n/a | Food, Beverage & Tobacco | ||
AXSM | US$97.37 | 7.4% | 63.1% | US$4.7b | US$129.18 | PS13.9x | E70.1% | n/a | Pharmaceuticals & Biotech | ||
TGTX | US$30.85 | 10.6% | 173.9% | US$5.0b | US$37.22 | PS16.7x | E56.5% | n/a | Pharmaceuticals & Biotech | ||
ALKT | US$36.90 | -2.3% | 63.5% | US$3.8b | US$44.30 | PS11.8x | E98.6% | n/a | Software | ||
ONON | US$53.35 | 5.9% | 96.6% | US$16.9b | US$57.57 | PE120.8x | E29.8% | n/a | Consumer Durables | ||
TVTX | US$18.47 | 4.6% | 207.3% | US$1.6b | US$26.38 | PS7.9x | E72.6% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$9.03 | 2.5% | 111.0% | US$462.2m | US$20.14 | PS19.7x | E73.2% | n/a | Pharmaceuticals & Biotech | ||
FWRY | ج.م8.40 | 2.7% | 66.3% | ج.م28.6b | ج.م11.39 | PE29.7x | E28.7% | n/a | Diversified Financials | ||
CRDO | US$41.90 | -10.9% | 136.9% | US$7.6b | US$37.58 | PS32x | E95.0% | n/a | Semiconductors | ||
ALNY | US$257.91 | -5.3% | 52.6% | US$34.1b | US$301.40 | PS15.9x | E70.7% | n/a | Pharmaceuticals & Biotech | ||
GAU | CA$2.03 | -9.4% | 141.7% | CA$516.4m | CA$3.51 | PS2.2x | E89.2% | n/a | Materials | ||
RMDA | ج.م3.56 | -1.9% | 135.1% | ج.م5.4b | ج.م4.11 | PE23.6x | E30.2% | 1.9% | Pharmaceuticals & Biotech | ||
ARES | US$169.02 | 0.4% | 65.7% | US$52.4b | US$172.31 | PE78.9x | E33.4% | 2.2% | Diversified Financials | ||
PRL | CA$35.71 | -10.0% | 258.9% | CA$1.3b | CA$43.32 | PE20.2x | E37.6% | 1.6% | Diversified Financials | ||
SRPT | US$109.11 | -9.4% | 31.5% | US$10.7b | US$189.86 | PE85.5x | E42.6% | n/a | Pharmaceuticals & Biotech | ||
EH | US$16.58 | -4.9% | 15.3% | US$1.1b | US$24.35 | PS30.5x | E81.4% | n/a | Capital Goods | ||
NVDA | US$146.76 | -1.4% | 196.6% | US$3.6t | US$157.72 | PE67.9x | E23.3% | 0.03% | Semiconductors | ||
7373 | JP¥1,595.00 | -0.9% | -13.6% | JP¥24.4b | JP¥4,700.00 | PE17.1x | E22.5% | 1.9% | Commercial Services | ||
A178320 | ₩28,750.00 | -2.4% | 54.4% | ₩1.6t | ₩39,333.33 | PE31.3x | E52.4% | 0% | Tech |